From AHLA’s Life Sciences Practice Group: FDA’s Final Guidance on Firm Communication to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products
- February 13, 2025
You must be logged in to access this content.